Skip to main content
. 2017 Sep 8;7:11006. doi: 10.1038/s41598-017-11212-1

Figure 3.

Figure 3

Blocking MGAT5-mediated N-glycosylation suppresses Gal-1-induced hepatic stellate cell (HSC) migration. (A) Schematic representation of N-glycan biosynthesis. (B) An N-glycan inhibitor (swainsonine, SW) inhibits L-PHA binding to LX-2 cells. (C) SW inhibits Gal-1 binding to LX-2 cells. (D) SW suppresses Gal-1-induced LX-2 cell migration. (E) Knockdown of MGAT5 inhibits L-PHA binding to LX-2 cells. (F) MGAT5 siRNAs suppress MGAT5 expression. (G) MGAT5 siRNAs inhibit Gal-1-induced LX-2 cell migration. LX-2 cells were treated with SW or transfected with MGAT5 siRNA for 48 h followed by incubation with L-PHA and Gal-1-488 to detect their binding to LX-2 cells using flow cytometry. The black line represents the binding of LX-2 cells with DyLight® 488 strepavidin alone and the brown line represents LX-2 cells without staining. To measure the migratory ability, cells were treated with 500 nM Gal-1 for 16 h. Migrated cells were counted, and results are presented as the mean ± SEM of three independent experiments. *p < 0.05.